Company Performance: MNOV's revenue, profitability, and pipeline progress directly impact investor confidence. Positive clinical trial results or FDA approvals typically boost the stock.

Market Sentiment: General market trends, investor risk appetite, and sector-specific optimism or pessimism influence MNOV's price. A bullish market often lifts all stocks.

Competitor Activity: Actions by competing companies in the biotechnology or drug development space can affect MNOV. New drug launches or clinical trial setbacks by competitors can impact MNOV's valuation.

Regulatory Environment: Changes in regulations pertaining to drug approvals, pricing, or healthcare policies can significantly influence MNOV's prospects and stock price.

Macroeconomic Factors: Economic indicators like interest rates, inflation, and GDP growth can indirectly impact MNOV. Higher interest rates might make it more expensive for MNOV to borrow money.

News and Announcements: Major news events, such as partnerships, acquisitions, or regulatory decisions, can trigger significant price movements in MNOV.